ICML 2025: Blood Test Shows Promise for Tracking Lymphoma Relapse Risk
Real-world data presented at the 2025 International Conference on Malignant Lymphoma (ICML) has provided new insights into the use of clonoSEQ, a circulating tumour DNA (ctDNA) assay…